MedTrace Logo

MPP Narrow QRS:Pilot Study on Multipoint Pacing in Patients With QRS Beetwen 100 and 130 Msec

NCT02402816 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-02-19

No results posted yet for this study

Summary

The purpose of this study is to assess the impact of the Multi Point Pacing (MPP) feature in the treatment of patients with QRS beetwen 100 and 130 msec in patients candidate to ICD implant.

Conditions

Interventions

DEVICE

MultiPoint Pacing ON

MultiPoint Pacing ON

DEVICE

Implantable cardioverter-defibrillator (ICD)

Implantable cardioverter-defibrillator (ICD)

Sponsors & Collaborators

  • Humanitas Hospital, Italy

    lead OTHER

Principal Investigators

  • Maurizio Gasparini, MD · Humanitas Research Hospital-Rozzano-Italy

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-05-31
Completion
2018-05-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02402816 on ClinicalTrials.gov